Helicobacter Pylori Testing Market Analysis And Forecast To 2031: By Test (Invasive, Non-Invasive), By Method (Point-of-Care (POC) Test, Laboratory Based Test), By End-use (Hospitals, Clinics, Diagnostic Laboratories), And Region

The global Helicobacter Pylori Testing Market was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period.

Helicobacter pylori testing is a way to determine if a person has an infection with the bacteria Helicobacter pylori. This bacteria is known to cause stomach ulcers, and testing can help to diagnose an infection and determine the best course of treatment. There are a few different ways to test for H. pylori, including a stool sample, a breath test, or a biopsy.

Global Helicobacter Pylori Testing Market Scope and Report Structure
Report Attribute Details
Market Size in 2021$436.0 mn
Market Size in 2031$915.4 mn
Growth Rate (2021-31)7.7 %
Historic Period2015-2020
Forecast Period2022-2031
Base Year2021
Segments CoveredTest Type, Method, End-user, and Region
Key CompaniesAbbott Laboratories, Avanos Corporate, Biohit Oyj, Bio-Rad Laboratories, Inc., Cardinal Health, Exalenz Bioscience Ltd., Gulf Coast Scientific, Medline Industries, Inc. , Thermo Fisher Scientific Inc. and QIAGEN.
Regional ScopeNorth America, Europe, Asia Pacific, Central & South America, Middle East & Africa
Analysis CoverageMarket Forecast, Competitive Landscape, Drivers, Trends, Restraints, Opportunities, Value-Chain, PESTLE, Key Events and Developments
Market Trends and Drivers

The most important driver of the H. pylori testing market is the high prevalence of H. pylori infection. It is estimated that H. pylori infects more than half of the world’s population. The prevalence is highest in developing countries and lowest in developed countries. The second important driver of the H. pylori testing market is the increasing awareness of the link between H. pylori infection and gastric cancer. Gastric cancer is the fourth most common cancer in the world and the second leading cause of cancer death. H. pylori infection is a major risk factor for gastric cancer. The third important driver of the H. pylori testing market is the increasing incidence of ulcers. Ulcers are a common condition and their incidence is increasing due to the increasing prevalence of H. pylori infection. The fourth important driver of the H. pylori testing market is the increasing demand for rapid and accurate testing methods. The currently available methods for H. pylori testing are culture, histology, urea breath test, and stool antigen test. However, these methods are time-consuming and expensive. The fifth important driver of the H. pylori testing market is the development of new and improved testing methods. Newer methods, such as PCR and ELISA, are more rapid and accurate than the older methods.

Market Restraints and Challenges

Helicobacter pylori infection is typically diagnosed through an invasive procedure, which entails biopsy and endoscopy, and requires advanced operational skills for precisely diagnosing and identifying the appropriate treatment method. However, the lack of trained professionals in nations with limited healthcare resources may affect the disease testing rates, dampening the market progress. Many low and middle-income economies lack the hospital and medical training infrastructure needed to highly skilled physicians. Helicobacter pylori treatment also poses other challenges for physicians as no first-line therapy can treat the infection for all patients.

Global Helicobacter Pylori Testing Market Segmental Overview

The report analyses the global Helicobacter Pylori Testing Market based on test type, method, end-user, and region.

Global Helicobacter Pylori Testing Market by Test Type

Based on test type, the market is segregated as Invasive, and Non-invasive. Amongst them, invasive helicobacter test segment is poised to register a significant CAGR from 2023 to 2031, driven by the efficacy and cost-effectiveness of rapid urease tests. The demand for invasive testing method is also high among patients do not correspond well to antibiotic therapy, have symptoms of severe gastric problems, and further require gastric endoscopy.

Global Helicobacter Pylori Testing Market by Method

On the basis of the method, the helicobacter pylori testing market is categorized into laboratory-based tests and point-of-care (POC) tests. The POC tests segment accounted for a significant business share in 2022, due to its non-invasive nature and its ability to deliver fast results. This is also attributed to collaborative research initiatives by leading industry giants and increasing R&D spending, which is further encouraging technological advancements as well as new product launches.

Global Helicobacter Pylori Testing Market by End-user

With regards to end-user, the Helicobacter Pylori Testing Market is divided into Hospital & Clinics, Diagnostic labs, and others. Hospital & Clinics generated considerable revenue in 2021 and is expected to grow at a highest CAGR over the analysis period. This is owing to the rising patient preference for clinics due to affordability and quality care. This is driven by the high-quality treatment and quick assistance offered by clinics, which provides the desired treatment results at a reasonable cost. In addition, the high-end services offered by clinics through effective disease management strategies are further set to spur segment expansion.

Geographical Analysis of Global Helicobacter Pylori Testing Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. North America Helicobacter Pylori Testing Market revenue is poised to grow significant CAGR during the forthcoming years. This can be attributed to the presence of industry leaders, as well as an emphasis on continual technological developments and new product releases, has contributed to the regional market’s growth. Revenue growth is slated to be fueled by the rising occurrences of infectious ailments and increasing aging population in the region. Poor healthcare infrastructure and low awareness about good sanitary practices across developing APAC economies is further projected to fuel the demand for helicobacter pylori tests.

Major Players in the Global Helicobacter Pylori Testing Market

The key players in the Helicobacter Pylori Testing Market Abbott LaboratoriesAvanos CorporateBiohit OyjBio-Rad Laboratories, Inc.Cardinal HealthExalenz Bioscience Ltd.Gulf Coast ScientificMedline Industries, Inc. Thermo Fisher Scientific Inc. and QIAGEN. among others.

COVID-19 Impact

In the initial months of 2020, COVID-19 made a severe negative impact on the h. pylori testing industry. Many h. pylori patients avoided hospital visits on account of the rapidly increasing COVID-19 cases and mortality rates, which overwhelmed healthcare facilities and spread infection fears among the global population. Additionally, the infection risks associated with invasive helicobacter pylori testing at point-of-care treatment units also led to disruption in the sector. Since the route of virus transmission is nasal or oral, the non-invasive tests such as the urea breath tests (UBT) were also impacted as they held a high possibility of COVID-19 transmission. Now, as successful vaccination drives turn COVID-19 into an afterthought, the market is expected to bounce back in a notable manner.

Recent Developments
  • In June 2022, Phathom Pharmaceuticals announced that FDA approved Voquenza (vonoprazan fumarate), in combination with anti-biotics, for H.pylori infection.
  • In September 2021, Phathom Pharmaceuticals Submited two NDAs to U.S. FDA for Vonoprazan-based treatment regimens for the treatment of H. pylori infection.
  • In July 2021, Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.
  • In March 2020, RedHill Biopharma Ltd., announced the U.S. commercial launch of Talicia® 1 delayed-release capsules 10 mg2/250 mg/12.5 mg for the treatment of Helicobacter pylori (H. pylori) infection in adults. RedHills expanded U.S. sales force will promote Talicia® nationwide to approximately 25,000 gastroenterologists, primary care physicians and other healthcare providers.
Frequently Asked Questions

Q1. How big is the Helicobacter Pylori Testing Market ?

Ans. The global Helicobacter Pylori Testing Market was valued at USD 436.0 Million in 2021 and it is anticipated to grow up to USD 915.4 Million by 2031, at a CAGR of 7.7% during the forecast period.

Q2. What is the Helicobacter Pylori Testing Market growth rate?

Ans. The growth rate of the Helicobacter Pylori Testing Market is 17.1%.

Q3. Which region holds a major market share for the market?

Ans. North America holds a major market share of the Helicobacter Pylori Testing Market in 2021.

Q4. Which segment accounted for the largest Helicobacter Pylori Testing Market share?

Ans. By end user, the hospital& clinics segment accounted for the largest Helicobacter Pylori Testing Market share.

Q5. Who are the key players in the digital diabetes management market?

Ans. The global Helicobacter Pylori Testing Market report includes players such as  Abbott LaboratoriesAvanos CorporateBiohit OyjBio-Rad Laboratories, Inc.Cardinal HealthExalenz Bioscience Ltd.Gulf Coast ScientificMedline Industries, Inc. Thermo Fisher Scientific Inc. and QIAGEN, among others.

Q6. What are the factors driving the Helicobacter Pylori Testing Market growth?

Ans. The major factors driving the growth of the market are growing prevalence of H, pylori across the globe.

Q7. What are the key growth strategies of Helicobacter Pylori Testing Market players?

Ans. The key growth strategies of Helicobacter Pylori Testing Market players are product launch and product approval.

Q8. Which region will provide more business opportunities for the Helicobacter Pylori Testing Market during the forecast period?

Ans. The Asia-Pacific region will provide more business opportunities for the Helicobacter Pylori Testing Market during the forecast period.

Table of Contents

Chapter 1. Helicobacter Pylori Testing Market Overview
1.1. Objectives of the Study
1.2. Market Definition and Research & Scope
1.3. Research Limitations
1.4. Research Methodologies
1.4.1. Secondary Research
1.4.2. Market Size Estimation Technique
1.4.3. Forecasting
1.4.4. Primary Research and Data Validation

Chapter 2. Executive Summary
2.1. Summary
2.2. Key Highlights of the Market

Chapter 3. Premium Insights on the Market
3.1. Market Attractiveness Analysis, by Region
3.2. Market Attractiveness Analysis, by Test Type
3.3. Market Attractiveness Analysis, by Method
3.4. Market Attractiveness Analysis, by End-user

Chapter 4. Helicobacter Pylori Testing Market Outlook
4.1. Helicobacter Pylori Testing Market Segmentation
4.2. Market Dynamics
4.2.1. Market Drivers
4.2.1.1. Driver 1
4.2.1.2. Driver 2
4.2.1.3. Driver 3
4.2.2. Market Restraints
4.2.2.1. Restraint 1
4.2.2.2. Restraint 2
4.2.3. Market Opportunities
4.2.3.1. Opportunity 1
4.2.3.2. Opportunity 2
4.3. Porter’s Five Forces Analysis
4.3.1. Threat of New Entrants
4.3.2. Threat of Substitutes
4.3.3. Bargaining Power of Buyers
4.3.4. Bargaining Power of Supplier
4.3.5. Competitive Rivalry
4.4. PESTLE Analysis
4.5. Value Chain Analysis
4.5.1. Raw Industry Vertical Suppliers
4.5.2. Manufacturers
4.5.3. Wholesalers and/or Retailers
4.6. Impact of COVID-19 on the Helicobacter Pylori Testing Market
4.7. Impact of the Russia and Ukraine War on the Helicobacter Pylori Testing Market

Chapter 5. Helicobacter Pylori Testing Market by Test Type
5.1. Market Overview
5.2. Invasive
5.2.1. Key Market Trends & Opportunity Analysis
5.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
5.3. Non-invasive
5.3.1. Key Market Trends & Opportunity Analysis
5.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 6. Helicobacter Pylori Testing Market by Method
6.1. Market Overview
6.2. Point of care (POC) Tests
6.2.1. Market Trends & Opportunity Analysis
6.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
6.3. Laboratory Based Tests
6.3.1. Market Trends & Opportunity Analysis
6.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 7. Helicobacter Pylori Testing Market by End-user
7.1. Market Overview
7.2. Hospital & Clinics
7.2.1. Key Market Trends & Opportunity Analysis
7.2.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.3. Diagnostic Labs
7.3.1. Key Market Trends & Opportunity Analysis
7.3.2. Market Size and Forecast, by Region, 2021-2031 ($Million)
7.4. Others
7.4.1. Key Market Trends & Opportunity Analysis
7.4.2. Market Size and Forecast, by Region, 2021-2031 ($Million)

Chapter 8. Flexible Endoscope Market, by Region
8.1. Overview
8.2. North America
8.2.1. Key Market Trends & Opportunity Analysis
8.2.2. North America Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.2.3. North America Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.2.4. North America Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.2.5. North America Helicobacter Pylori Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.2.6. The U.S.
8.2.6.1. The U.S. Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.2.6.2. The U.S. Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.2.6.3. The U.S. Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.2.7. Canada
8.2.7.1. Canada Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.2.7.2. Canada Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.2.7.3. Canada Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.2.8. Mexico
8.2.8.1. Mexico Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.2.8.2. Mexico Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.2.8.3. Mexico Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3. Europe
8.3.1. Key Market Trends & Opportunity Analysis
8.3.2. Europe Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.3. Europe Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.4. Europe Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.5. Europe Helicobacter Pylori Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.3.6. Germany
8.3.6.1. Germany Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.6.2. Germany Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.6.3. Germany Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.7. France
8.3.7.1. France Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.7.2. France Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.7.3. France Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.8. U.K.
8.3.8.1. U.K. Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.8.2. U.K. Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.8.3. U.K. Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.9. Spain
8.3.9.1. Spain Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.9.2. Spain Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.9.3. Spain Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.10. Italy
8.3.10.1. Italy Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.10.2. Italy Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.10.3. Italy Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.3.11. Rest of Europe
8.3.11.1. Rest of Europe Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.3.11.2. Rest of Europe Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.3.11.3. Rest of Europe Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4. Asia-Pacific
8.4.1. Key Market Trends & Opportunity Analysis
8.4.2. Asia-Pacific Helicobacter Pylori Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.4.3. Asia-Pacific Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.4.4. Asia-Pacific Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.4.5. Asia-Pacific Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.6. China
8.4.6.1. China Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.4.6.2. China Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.4.6.3. China Helicobacter Pylori Testing Market Size and Forecast by Test Type Industry Vertical, 2021-2031, ($Million)
8.4.7. India
8.4.7.1. India Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.4.7.2. India Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.4.7.3. India Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.8. Japan
8.4.8.1. Japan Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.4.8.2. Japan Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.4.8.3. Japan Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.9. South Korea
8.4.9.1. South Korea Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.4.9.2. South Korea Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.4.9.3. South Korea Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.4.10. Rest of APAC
8.4.10.1. Rest of APAC Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.4.10.2. Rest of APAC Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.4.10.3. Rest of APAC Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5. Rest of the World
8.5.1. Key Market Trends & Opportunity Analysis
8.5.2. Rest of the World Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.5.3. Rest of the World Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.5.4. Rest of the World Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5.5. Rest of the World Helicobacter Pylori Testing Market Size and Forecast by Country, 2021-2031, ($Million)
8.5.6. Latin America
8.5.6.1. Latin America Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.5.6.2. Latin America Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.5.6.3. Latin America Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5.7. Middle East
8.5.7.1. Middle East Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.5.7.2. Middle East Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.5.7.3. Middle East Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)
8.5.8. Africa
8.5.8.1. Africa Helicobacter Pylori Testing Market Size and Forecast by Test Type, 2021-2031, ($Million)
8.5.8.2. Africa Helicobacter Pylori Testing Market Size and Forecast by Method, 2021-2031, ($Million)
8.5.8.3. Africa Helicobacter Pylori Testing Market Size and Forecast by End-user, 2021-2031, ($Million)

Chapter 9. Competitive Landscape
9.1. Market Overview
9.2. Market Share Analysis/Key Player Positioning
9.3. Vendor Benchmarking
9.4. Developmental Strategy Benchmarking
9.4.1. New Product Development
9.4.2. Product Launches
9.4.3. Business Expansions
9.4.4. Partnerships, Joint Ventures, and Collaborations
9.4.5. Mergers and Acquisitions

Chapter 10. Company Profiles
10.1. Abbott Laboratories
10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Offerings
10.1.4. Key Strategic Initiatives
10.1.5. SWOT Analysis
10.2. Avanos Corporate
10.2.1. Company Snapshot
10.2.2. Financial Performance
10.2.3. Product Offerings
10.2.4. Key Strategic Initiatives
10.2.5. SWOT Analysis
10.3. Biohit Oyj
10.3.1. Company Snapshot
10.3.2. Financial Performance
10.3.3. Product Offerings
10.3.4. Key Strategic Initiatives
10.3.5. SWOT Analysis
10.4. Bio-Rad Laboratories, Inc.
10.4.1. Company Snapshot
10.4.2. Financial Performance
10.4.3. Product Offerings
10.4.4. Key Strategic Initiatives
10.4.5. SWOT Analysis
10.5. Cardinal Health
10.5.1. Company Snapshot
10.5.2. Financial Performance
10.5.3. Product Offerings
10.5.4. Key Strategic Initiatives
10.5.5. SWOT Analysis
10.6. Exalenz Bioscience Ltd.
10.6.1. Company Snapshot
10.6.2. Financial Performance
10.6.3. Product Offerings
10.6.4. Key Strategic Initiatives
10.6.5. SWOT Analysis
10.7. Gulf Coast Scientific
10.7.1. Company Snapshot
10.7.2. Financial Performance
10.7.3. Product Offerings
10.7.4. Key Strategic Initiatives
10.7.5. SWOT Analysis
10.8. Medline Industries, Inc.
10.8.1. Company Snapshot
10.8.2. Financial Performance
10.8.3. Product Offerings
10.8.4. Key Strategic Initiatives
10.8.5. SWOT Analysis
10.9. Thermo Fisher Scientific Inc.
10.9.1. Company Snapshot
10.9.2. Financial Performance
10.9.3. Product Offerings
10.9.4. Key Strategic Initiatives
10.9.5. SWOT Analysis
10.10. QIAGEN
10.10.1. Company Snapshot
10.10.2. Financial Performance
10.10.3. Product Offerings
10.10.4. Key Strategic Initiatives
10.10.5. SWOT Analysis
*The list of company is subject to change during the final compilation of the report

Global Helicobacter Pylori Testing Market Segmentation

By Test Type

  • Invasive
  • Non-invasive

By Method

  • Point of care (POC) Tests
  • Laboratory Based Tests

By End-user

  • Hospital & Clinics
  • Diagnostic labs
  • Others

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Rest of World
    • Latin America
    • Middle East
    • Africa

Order this Report

Have questions about the scope of the report ?

Have specific requirements ?

Budget Constraints ?

Related Reports

Vitiligo is a chronic disorder that causes patches…
The global Histopathology Services Market was valued at…
Radiation oncology is a branch of medicine that…
Genetic genealogy is a branch of genealogy that…
Cell line development is a process used for…
Urticaria is an itchy rash that appears on…
The genome editing market size was USD 7.58…
Nicotine pouches are a type of smokeless tobacco…
Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect…
Clinical trial supplies are the materials and products…